advanced search

INJECTION

PHARMA PARTNERING CONSIDERATIONS FOR INJECTION DEVICE COMPONENTS
EXPERT VIEW
Adam Shain
PHARMA PARTNERING CONSIDERATIONS FOR INJECTION DEVICE COMPONENTS
In the modern world of injectable drugs, one of the major considerations for pharma is choosing partner companies for the development and manufacture of the injection device components. Adam Shain, discusses several of the considerations that go into ensuring that the best possible partner is selected.
CONNECTED, NEEDLE-FREE DRUG DELIVERY
INJECTION
Barbara Taylor
Portal Instruments
CONNECTED, NEEDLE-FREE DRUG DELIVERY
The healthcare industry is seeing an ever growing trend towards patients self-administering their therapies at home. Barbara Taylor discusses this trend and how Portal is making a bold step towards this goal with its novel needle-free injection device.
ENABLE INJECTIONS AND FLEX SET AMBITIOUS PLANS FOR LARGE VOLUME DRUG DELIVERY
WEARABLES
John Love
Enable Injections
ENABLE INJECTIONS AND FLEX SET AMBITIOUS PLANS FOR LARGE VOLUME DRUG DELIVERY
The delivery of high volumes of biologics outside of the clinical setting remains a key challenge in the industry. Here, John Love, Mark Lee and Amy Boyle discuss how the enFuse™ on-body injector, developed by Enable in partnership with Flex, may be the answer.
THE SECRET TO A SINGLE AUTOINJECTOR DESIGN FOR MULTIPLE MEDICATIONS
PREFILLED SYRINGES
David Philbrick
Paragon Medical
THE SECRET TO A SINGLE AUTOINJECTOR DESIGN FOR MULTIPLE MEDICATIONS
The autoinjector market is booming and is predicted to continue doing so for some time to come. In order to capitalise on this, pharma companies are looking to use their autoinjectors for multiple medications. David Philbrick presents the case for bringing on metal component manufacturers in the initial design phase to make the most out of the crucial expertise they can offer.
AN INTRADERMAL PLATFORM BUILT FOR INDUSTRY AND PATIENTS
EARLY INSIGHT
Dr Moe Wehbe
AN INTRADERMAL PLATFORM BUILT FOR INDUSTRY AND PATIENTS
Moe Wehbe, Iman Mansoor and Sahan Ranamukha discuss the potential of intradermal injection for modern medicines and its advantages over the subcutaneous route.
INJECTING HIGH VOLUME, HIGH VISCOSITY DRUGS
PREFILLED SYRINGES
SHL Medical
INJECTING HIGH VOLUME, HIGH VISCOSITY DRUGS
SHL details its latest offerings in the world of biologics, as well as its partnership with QuiO, a speciality digital healthcare start-up, to develop injectables in the connected healthcare space.
SUPERCAPSYRINGE<sup>®</sup> PASSES THE TEST
INJECTION
Hans Peter Manser
SUPERCAPSYRINGE® PASSES THE TEST
Hans Peter Manser, Lisa Lippuner and Sarah Raible discuss the findings of a study conducted to test the qualities of Weibel’s SuperCapSyringe®.
FROM PREFILLED SYRINGES TO COMBI-FILLING
EXPERT VIEW
Klaus Ullher
FROM PREFILLED SYRINGES TO COMBI-FILLING
Klaus Ullherr summarises the state of modern packaging technology in the pharmaceutical industry in the light of the biotech boom, ready-to-fill and pre-sterilised containers and the trend towards individualised healthcare.
CONTROLLING AUTOINJECTOR NEEDLE INSERTION AND INJECTION SPEED
PREFILLED SYRINGES
Pascal Dugand
CONTROLLING AUTOINJECTOR NEEDLE INSERTION AND INJECTION SPEED
Pascal Dugand relates a study conducted by Nemera to determine a way to optimise the transition from needle insertion to syringe emptying for parenteral devices. This piece was originally presented as a poster at PDA Vienna 2017.
AN OPTIMISED PLATFORM FOR HIGHLY SENSITIVE BIOLOGICS
PREFILLED SYRINGES
Alessio Bonati
Stevanato Group
AN OPTIMISED PLATFORM FOR HIGHLY SENSITIVE BIOLOGICS
Alessio Bonati discusses the problematic interactions between drugs and their primary containers and goes on to introduce the Alba platform, Ompi’s range of primary glass containers designed to unify drug-container interactions over a product’s lifecycle.
PREFILLABLE SYRINGE DEVELOPMENTS TO MEET BIOTECH DRUG NEEDS
PREFILLED SYRINGES
Claudia Petersen
Gerresheimer
PREFILLABLE SYRINGE DEVELOPMENTS TO MEET BIOTECH DRUG NEEDS
Claudia Petersen looks at the technological advances being made to ensure prefillable syringes are compatible with protein-based, biotech-derived drugs.
DIGITISATION & INDUSTRY 4.0 IN PHARMA PRODUCTION
INJECTION
Christoph Hammer
DIGITISATION & INDUSTRY 4.0 IN PHARMA PRODUCTION
Christoph Hammer gives an overview of the Industry 4.0 concept, and its pharmaceutical application Pharma 4.0. Furthermore, Mr Hammer provides examples of what Pharma 4.0 can offer, discussing solutions shown at Interpak 2017, Düsseldorf.
SUNDEEP KANKANALA, BD
INTERVIEW
Dr Sundeep Kankanala
BD (Becton Dickinson & Company)
SUNDEEP KANKANALA, BD
Sundeep Kankanala discusses the challenges faced by today’s biopharmaceutical industry, in particular those posed by the need for large volumes and the issues caused by the use of silicone in prefilled syringes.
A NOVEL PRECISION-TARGETED ENDOVASCULAR DELIVERY SYSTEM
INJECTION
Paul J Fitzpatrick
A NOVEL PRECISION-TARGETED ENDOVASCULAR DELIVERY SYSTEM
Paul J Fitzpatrick introduces the Occlusion Perfusion Catheter™, an innovative device that can target high concentrations of drug to precisely defined locations.
CRITICAL CONSIDERATIONS FOR HIGH VISCOSITY/HIGH VOLUME DEVICES
PREFILLED SYRINGES
Bill Welch
Phillips Medisize
CRITICAL CONSIDERATIONS FOR HIGH VISCOSITY/HIGH VOLUME DEVICES
There are some device design considerations that are common across the spectrum of biologics development. Bill Welch discusses these considerations, highlighting the advantage conferred by accounting for them early in the product lifecycle.
JOHN A MERHIGE, CREDENCE MEDSYSTEMS
INTERVIEW
John Merhige
Credence MedSystems
JOHN A MERHIGE, CREDENCE MEDSYSTEMS
John Merhige discusses Credence’s Companion Safety Syringe System, new advances in the product development pipeline, customer/market driven feedback from user studies and exciting developments planned for 2018 that will take the company on to the next major phase in its growth.
RECONSTITUTION DEVICES: MIXING, POWER, PACKAGING & REGULATION
EXPERT VIEW
Charlotte Harvey
RECONSTITUTION DEVICES: MIXING, POWER, PACKAGING & REGULATION
Charlotte Harvey discusses the challenge of reconstituting lyophilised drugs, both from the perspective of the drug itself and the delivery device associated with it.
THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS
PREFILLED SYRINGES
Dr Karen Guerrero
BD (Becton Dickinson & Company)
THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS
Karen Guerrero outlines how human factors engineering, now an essential requirement for all new drug delivery combination product approvals, can represent a significant challenge and how BD can help streamline this aspect of the development process.
ADDRESSING HUMAN FACTORS STUDIES AT AN EARLY STAGE
PREFILLED SYRINGES
Dr Jakob Lange
Ypsomed
ADDRESSING HUMAN FACTORS STUDIES AT AN EARLY STAGE
Orfeo Niedermann and Jakob Lange provide insights into the development of platform products that offer pharma companies low risks and shorter timelines at an attractive cost, using the examples of the YpsoMate autoinjector and UnoPen pen injector platform products.
A PATIENT-CENTRIC APPROACH TO THERAPY MANAGEMENT
EXPERT VIEW
Karl Hewson
A PATIENT-CENTRIC APPROACH TO THERAPY MANAGEMENT
Karl Hewson and Uri Baruch discuss the challenges presented by chronic illness, and look ahead to a better future of patient-centric treatment, personalised to each individual’s needs.
IMPROVING PATIENT EXPERIENCE WITH NEW ONBOARDING TECHNIQUES
PREFILLED SYRINGES
Paul Sullivan
Noble
IMPROVING PATIENT EXPERIENCE WITH NEW ONBOARDING TECHNIQUES
Paul Sullivan outlines how the growing trend towards patient self-injection, outside of the clinical setting, places an ever greater emphasis on quality training and onboarding. Mr Sullivan specifically explains how such training can help overcome the issue of patient needle fear or anxiety.
IMPROVING PATIENTS’ LIVES THROUGH CONNECTIVITY
CONNECTIVITY
Matthieu Hamon
Biocorp
IMPROVING PATIENTS’ LIVES THROUGH CONNECTIVITY
Eric Dessertenne and Matthieu Hamon look at the importance of increasing the connectivity of drug delivery devices to improve patient compliance in the area of chronic disease management. Biocorp aims to use innovations such as Datapen™ and EasyLog™ to help create patient-centric, interconnected care, known as 4P medicine.
A NEW VALUE PROPOSITION OF SMART DEVICES: ADVANCED MEDICATION ADHERENCE MONITORING IN CLINICAL TRIALS
PREFILLED SYRINGES
Dr Andreas Schneider
Ypsomed
A NEW VALUE PROPOSITION OF SMART DEVICES: ADVANCED MEDICATION ADHERENCE MONITORING IN CLINICAL TRIALS
Andreas Schneider explores a new value proposition of smart injection systems, introducing how advanced adherence monitoring services resolve some of the key challenges of clinical research practice regarding costs, adherence, data quality and integrity, Dr Schneider explains which technical features are needed for smart devices to provide value-adding adherence monitoring services, using SmartPilot for YpsoMate as a case study.
PRODUCT SHOWCASE: APTAR PHARMA’S PREMIUM PORTFOLIO
PREFILLED SYRINGES
Arnaud Fournier
Aptar Pharma
PRODUCT SHOWCASE: APTAR PHARMA’S PREMIUM PORTFOLIO
For over 50 years Aptar Pharma’s injectables specialists have led the way in developing innovative elastomer solutions. Their commitment to continuous improvement has resulted in elastomer formulations that feature best-in-class extractables and leachables profiles.
Top